Synonyms: EYEOO1 | Macugen® | NX183 | pegaptanib sodium
pegaptanib is an approved drug (FDA (2004), EMA (2006))
Compound class:
Nucleic acid
Comment: Pegaptanib is a RNA oligonucleotide aptamer that acts as a vascular endothelial growth factor A antagonist, anti-angiogenic agent.
It is a 28-mer RNA oligonucleotide that is covalently linked to two branched 20-kD polyethylene glycol (PEG) chains. Pegaptanib binds to the 165 isoform of VEGFA. It is formulated as a sodium adduct. The basic nucleotide sequence has modified nucleotides and a 5' pentylamino linker that acts as the PEG anchor. |
|
Classification | |
Compound class | Nucleic acid |
Compound subclass | Aptamer |
Target | Vascular endothelial growth factor A |
Approved drug? | Yes (FDA (2004), EMA (2006)) |
International Nonproprietary Names | |
INN number | INN |
8215 | pegaptanib |
Synonyms |
EYEOO1 | Macugen® | NX183 | pegaptanib sodium |
Database Links | |
Specialist databases | |
Reactome Drug | R-ALL-9679463 |
Reactome Reaction | R-HSA-9679477 |
Other databases | |
CAS Registry No. | 222716-86-1 (source: WHO INN record) |
DrugBank Ligand | DB04895 |
GtoPdb PubChem SID | 178103442 |
Search PubMed clinical trials | pegaptanib |
Search PubMed titles | pegaptanib |
Search PubMed titles/abstracts | pegaptanib |
Wikipedia | Pegaptanib |